PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Accugenix, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Accugenix Announces New CEO & President – Retains Former as R&D VP - Accugenix Announces New CEO & President, Retains Former as R&D VP Former COO Roger Nalepa takes the reins and former CEO Doug Smith refocuses on R&D
Accugenix Announces New CEO & President – Retains Former as R&D VP

 

NewswireToday - /newswire/ - Newark, DE, United States, 2008/11/26 - Accugenix Announces New CEO & President, Retains Former as R&D VP Former COO Roger Nalepa takes the reins and former CEO Doug Smith refocuses on R&D.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Accugenix, Inc. publicly announced today the promotion of former COO, Roger Nalepa, to the position of CEO & President, and the reassignment of former CEO Doug Smith to Vice President of Research & Development. Specializing in genetic microbial identification, the Delaware-based DNA sequencing lab described the recent reorganization as rejuvenation for both its strategic leadership and its exemplary cutting-edge technology.

"Doug and I have changed roles to command positions that capitalize on our strengths to further drive the business," said Nalepa, whose extensive 30-year history of management experience includes executive-level positions at Hewlett Packard and Agilent Technologies. “Our skill sets complement one another very well; Doug’s entrepreneurship and technical expertise have made him a leader in cutting-edge technology, whereas my management and international leadership experience have prepared me to coordinate our people to deliver our objectives and strategic vision.”

As CEO, Nalepa will provide strategic leadership for the company, working with the Board of Directors (presided over by Chairman Mark Martin) and the Executive Management Team to establish long-range goals, strategies and policies. He will assume fiduciary responsibility for protecting shareholder interests, and publicly represent Accugenix in the community. As R&D VP, Smith will direct all activities related to building the research and development function and its strategic direction. He will establish R&D initiatives for improving DNA sequencing assays, bacterial and fungal identification libraries, cost, and on-time delivery, continually innovating solutions to customer problems. Smith developed two microbial ID systems currently in use: he developed the fatty acid microbe ID system, while at Hewlett-Packard, and more recently, he developed the sequencing-based ID system MicroSEQ™ while at Applied Biosystems.

A founding Board member of Accugenix, Smith brought Nalepa on board nearly a year ago to utilize his business leadership savvy and has since helped familiarize him with the industry and the company’s focused, highly-specialized services. Nalepa agreed: “I’ve been with Accugenix long enough to feel very confident with my grasp on the technology, the industry, and our challenges and strategies. Doug has paved the way for this smooth transition aimed to energize the company and return him to what he does best and loves most—R&D.”

Indeed, Smith is excited to return to his passion and feels confident with Nalepa taking the reins: “Accugenix is looking to expand, and Roger has the leadership experience and demonstrated success for such a transition.”

As for Accugenix’s future, Nalepa plans to continue process improvements that support the company’s industry-leading reputation for genetic microbial identification: “we have always been and will continue to be a focused lab; we do sequence identification and we do it really well. We are the industry leader because we continue to use technology to solve customer problems—increasing quality and reducing cost to maintain consistent high performance for our customers.”

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Accugenix, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Accugenix Announces New CEO & President – Retains Former as R&D VP

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Roger Nalepa - Accugenix.com 
302-294-8564 rogernalepa[.]accugenix.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Accugenix, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Accugenix, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

First Pulmonary Embolism Patients in Hong Kong Treated with the EKOS® System
Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Genentech’s Cancer Immunotherapy Tecentriq® (Atezolizumab) Priority Review in Additional Type of Advanced Bladder Cancer
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) for Myopic Choroidal Neovascularization
Sugar Element of Keratan Sulfate Halts the Progress of Emphysema Finds RIKEN
Exelixis and Ipsen Amend Exclusive Licensing Agreement for the Commercialization and Development of Cabozantinib to Include Canada
FDA Extends Review of Application for OCREVUS™ (Ocrelizumab)
MDxHealth Announces AceCGT Life Science Limited as the Exclusive Distributor for SelectMDx in Hong Kong and Macao China
Pulse Certified As A Level Four Multichannel Content Agency by Veeva Systems
BD Launches Advanced Prefillable Syringe for Higher Volume Injection of Biologics
Sartorius Announces Expansion of Sartorius Stedim Cellca
Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
BD Integrating Technology, Expertise and Services to Provide Comprehensive Medication Management
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  1Click Games

Visit  JobsWare.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)